ReWalk Robotics Ltd. - Ordinary Shares LFWD 深 滬
等待開盤 08-06 09:30:00 美东时间
0.705
+0.005
+0.71%
華盛通- 最 高0.73
- 今 開0.73
- 成交量 22.58万股
- 最 低 0.6867
- 昨 收 0.70
- 總市值 776.04万
- 52周最高 4.00
- 市盈率 靜 --
- 換手率 2.05%
- 52周最低 0.501
- 委 比 -61.90%
- 總股本 1100.76万
- 歷史最高 7648.55
- 量 比 0.90
- 振 幅 6.19%
- 歷史最低 0.501
- 每 手 1
- 風險率 0.84%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region
Lifeward Ltd. expands its partnership with SportsMed Products Ltd. to distribute AlterG products in the UAE and GCC region through SportsMed Performance Trading LLC. This strategic move aims to strengthen AlterG's global reach, with SportsMed providing specialized training, servicing, and a new demo zone in Dubai showcasing the latest AlterG NEO+ system.
08-04 12:30
美股机会日报 | 超1000亿美元蓄势待发！美股或迎巨量买盘；特朗普酝酿提前“换帅”逼宫美联储降
标普500期货涨0.33%创历史新高！超1000亿美元蓄势待发，美股或迎巨量买盘；特朗普酝酿提前“换帅”逼宫美联储降息>>
06-26 20:09
美股盘前 | 美光科技绩后涨超2%；量子计算概念股走高
美光科技绩后涨超2%，Q4营收、利润指引超预期；量子计算概念股走高，IONQ涨超4%，QUBT涨超2%；部分热门中概股上涨，哔哩哔哩、霸王茶姬涨超1%>>
06-26 16:32
Lifeward stock plummets on pricing of $2.6M public offering
Lifeward (NASDAQ:LFWD) has announced the pricing of a public offering of an aggregate of 4M of the Co.’s ordinary shares and accompanying warrants to purchase up to 4M of the Co.’s ordinary shares, at...
06-25 21:17
Lifeward Prices $2.6M Public Offering Of 4M Shares And Warrants At A Combined Price Of $0.65
Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced the pricing of a
06-25 21:12
Lifeward Announces Pricing of $2.6 Million Public Offering
Lifeward Ltd. has announced a public offering of 4 million ordinary shares and warrants, priced at $0.65 each, with expected gross proceeds of $2.6 million. The warrants, exercisable immediately, expire in five years. Proceeds will support commercial efforts, working capital, and general corporate purposes. The offering is underwritten by H.C. Wainwright & Co. and registered with the SEC. Lifeward focuses on innovative medical technologies for in...
06-25 13:10
Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary
A recent ruling by an Administrative Law Judge (ALJ) has determined that the ReWalk Exoskeleton, developed by Lifeward Ltd., is a "reasonable and necessary" medical device for individuals with spinal cord injuries (SCI), allowing Medicare coverage for its use. This decision, which supports the medical necessity of the device, follows an April 2024 CMS ruling to finalize Medicare reimbursement for personal exoskeletons. The ReWalk Exoskeleton enab...
06-24 20:05
Lifeward appoints Mark Grant as CEO
Lifeward (NASDAQ:LFWD) announced on Monday that Mark Grant has been appointed as the company’s new president and chief executive officer, effective June 2, 2025. Larry Jasinski, Lifeward’s outgoing CE...
05-19 21:03
Lifeward Appoints Mark Grant As President And CEO, Effective June 2, 2025
Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that Mark Grant has
05-19 20:36
Lifeward Affirms FY2025 Sales Guidance of $28.00M-$30.00M vs $28.98M Est
Lifeward (NASDAQ:LFWD) affirms FY2025 sales outlook from $28.00 million-$30.00 million to $28.00 million-$30.00 million vs $28.98 million estimate.
05-15 20:03
